Mineralys Therapeutics, Inc. (MLYS): Shares Outstanding

Annual figures by period end, from SEC filings.

81.54M
As of 2025-12-31
88.35M
As of 2026-06-30
+133.3%
3-year compound annual growth
2022-12-31: 6.42M2023-12-31: 41.13M2024-12-31: 49.82M2025-12-31: 81.54M81.54M
2022-12-31 Shares Outstanding (shares) 2025-12-31
Period endedShares OutstandingChange YoYSource filing
2025-12-3181.54M+63.7%2026-03-12, Balance as of period end
2024-12-3149.82M+21.1%2026-03-12, Balance as of period end
2023-12-3141.13M+540.8%2025-02-12, Balance as of period end
2022-12-316.42Mn/a2024-03-21, Balance as of period end